Home
Natco Pharma Ltd Share Price History
Natco Pharma Ltd
NSE : 21 Feb, 2025
797.954.8 (0.6%)
Prev Close
793.2
Open Price
792.0
Bid Price (QTY)
-
Offer Price (QTY)
-
Volume
1508071
Today's High / Low
816.0 / 778.3
52 WK High / Low
1639.0 / 778.3
Market Price of Natco Pharma Ltd
1M
1Y
3Y
5Y
Monitoring Natco Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
History Market Price
| Date | Price | Open | High | Low |
|---|
Returns Comparison
1W
1M
3M
6M
1Y
3Y
5Y
10Y
Growth Parameters
| Parameter |  2017 |
|---|---|
| Sales (Cr.) | NaN |
| Sales YoY Gr. | - |
| Adj EPS | 27.79 |
| YoY Gr. | - |
| Net Profit (Cr.) | 485 |
| BVPS | 94.52 |
Key Financial Parameters
| Parameter | 2015 |
|---|---|
| Return on Capital Emp. % | 16.58 |
| Op. Profit Mgn % | 26.87 |
| Net Profit Mgn % | 16.85 |
| Debt to Equity % | 0.35 |
Latest Shareholding
Promoters Holdings Over Time
About Natco Pharma Ltd
- Natco Pharma Limited is a vertically integrated and R&D focused pharmaceutical company that specialises in development, manufacturing and marketing of Finished Dosage Formulations (FDF) and Active Pharmaceutical Ingredients (APIs).
- The Company's focus is primarily on niche therapeutic areas and complex products.
- It sells products in over 40 countries.
- FDF products are sold in the United States, India, Europe and the rest of the world (RoW).
- Natco's API products are primarily used for captive consumption in its FDF products and are also sold to customers for various international markets such as Brazil, Europe and USA. In the API segment, Natco has capabilities to develop and manufacture products with multi-step synthesis, semi synthetic fusion technologies, high-potency APIs and peptides. Natco Pharma is also engaged in contract manufacturing business, whereby the company undertakes selected contracts with pharmaceutical companies to manufacture and supply pharmaceutical products.
Popular Search
FAQs for Natco Pharma Ltd Share Price History
What are the key events that typically impact Natco Pharma Ltd's share price history?
Key events that impact Natco Pharma Ltd’s share price history include quarterly earnings releases, product launches, leadership changes, economic policies, and geopolitical developments.
How do stock splits affect Natco Pharma Ltd's share price history?
Stock splits reduce the nominal price of Natco Pharma Ltd's shares by increasing the number of outstanding shares, which typically makes the stock more accessible to a broader range of investors. Although the total market value of the company remains unchanged after the split, the split can affect investor perception and liquidity, potentially influencing the share price in the longer term.
How do dividends impact the share price history of Natco Pharma Ltd?
Dividends can influence Natco Pharma Ltd's share price history by typically causing a temporary dip on the ex-dividend date, as the stock price often adjusts to reflect the dividend payout. Over time, the impact of dividends on the share price may be offset by the company's overall financial performance and market conditions.
How do corporate announcements affect Natco Pharma Ltd’s share price history?
Corporate announcements such as mergers, acquisitions, or strategic shifts can lead to significant price changes. Any optimistic development news on Natco Pharma Ltd generally boosts the company’s share price, whereas negative news can lead to a decline in share price.
How can I use technical analysis to understand Natco Pharma Ltd’s share price history?
To understand Natco Pharma Ltd’s share price history using technical analysis, examine charts for patterns such as trends, support, and resistance levels, and apply indicators like moving averages or Relative Strength Index (RSI) to gauge potential future movements. Analyze historical data to identify recurring trends and signals that might suggest how the share price could behave under similar conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
